5/7/2013

Nuclear medicine company Digirad said it saw lower revenue and net income in the first quarter compared with the same period last year. The company said it also had lower revenue from its Diagnostic Imaging unit compared with last year. The firm attributes the decline in revenue to changes associated with its restructuring efforts.

Related Summaries